Copyright
©The Author(s) 2023.
World J Gastroenterol. Feb 7, 2023; 29(5): 851-866
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.851
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.851
Figure 8 Evolution of the levels of luminal adherent-invasive Escherichiacoli LF82 after surgery.
A: Weekly evaluation of the luminal LF82 Levels after surgery in HLA-B27 transgenic (Tg) rats and wild-type (nTg) rats receiving adherent-invasive Escherichia coli strain LF82 alone or Saccharomyces cerevisiae CNCM I-3856 and LF82; B: Global persistence of viable luminal LF82 after surgery and during the last 5 wk of the study in Tg rats receiving LF82 alone or CNCM I-3856 and LF82. cP < 0.001. CFU: Colony-forming unit; log10: Decimal logarithm.
- Citation: Valibouze C, Speca S, Dubuquoy C, Mourey F, M'Ba L, Schneider L, Titecat M, Foligné B, Genin M, Neut C, Zerbib P, Desreumaux P. Saccharomyces cerevisiae prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats. World J Gastroenterol 2023; 29(5): 851-866
- URL: https://www.wjgnet.com/1007-9327/full/v29/i5/851.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i5.851